Page last updated: 2024-10-29

ketamine and Temporomandibular Disorders

ketamine has been researched along with Temporomandibular Disorders in 4 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Research Excerpts

ExcerptRelevanceReference
" In this study 18 temporomandibular joint (TMJ) arthralgia patients received intra-articular injections of the N-methyl-D-aspartate (NMDA) receptor antagonist, ketamine, or normal saline to study in a cross-over, double-blinded, placebo-controlled manner the effect on TMJ pain and somatosensory function."9.13Effects of intra-articular ketamine on pain and somatosensory function in temporomandibular joint arthralgia patients. ( Ayesh, EE; Jensen, TS; Svensson, P, 2008)
"Remifentanil was the best agent for AFOI, because it provided shorter intubation time, better intubation conditions, and least patient's complaint."6.80Remifentanil, ketamine, and propofol in awake nasotracheal fiberoptic intubation in temporomandibular joint ankylosis surgery. ( Arabion, HR; Eftekharian, HR; Heydari, ST; Zarei, K, 2015)
" In this study 18 temporomandibular joint (TMJ) arthralgia patients received intra-articular injections of the N-methyl-D-aspartate (NMDA) receptor antagonist, ketamine, or normal saline to study in a cross-over, double-blinded, placebo-controlled manner the effect on TMJ pain and somatosensory function."5.13Effects of intra-articular ketamine on pain and somatosensory function in temporomandibular joint arthralgia patients. ( Ayesh, EE; Jensen, TS; Svensson, P, 2008)
"Remifentanil was the best agent for AFOI, because it provided shorter intubation time, better intubation conditions, and least patient's complaint."2.80Remifentanil, ketamine, and propofol in awake nasotracheal fiberoptic intubation in temporomandibular joint ankylosis surgery. ( Arabion, HR; Eftekharian, HR; Heydari, ST; Zarei, K, 2015)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eftekharian, HR1
Zarei, K1
Arabion, HR1
Heydari, ST1
Burgos, E1
Pascual, D1
Martín, MI1
Goicoechea, C1
Alstergren, P1
Ernberg, M1
Nilsson, M1
Hajati, AK1
Sessle, BJ1
Kopp, S1
Ayesh, EE1
Jensen, TS1
Svensson, P1

Trials

3 trials available for ketamine and Temporomandibular Disorders

ArticleYear
Remifentanil, ketamine, and propofol in awake nasotracheal fiberoptic intubation in temporomandibular joint ankylosis surgery.
    The Journal of craniofacial surgery, 2015, Volume: 26, Issue:1

    Topics: Adolescent; Adult; Anesthetics; Ankylosis; Conscious Sedation; Double-Blind Method; Female; Fiber Op

2015
Glutamate-induced temporomandibular joint pain in healthy individuals is partially mediated by peripheral NMDA receptors.
    Journal of orofacial pain, 2010,Spring, Volume: 24, Issue:2

    Topics: Adult; Area Under Curve; Double-Blind Method; Estradiol; Excitatory Amino Acid Antagonists; Excitato

2010
Effects of intra-articular ketamine on pain and somatosensory function in temporomandibular joint arthralgia patients.
    Pain, 2008, Jul-15, Volume: 137, Issue:2

    Topics: Adult; Afferent Pathways; Analgesics; Arthralgia; Cross-Over Studies; Dose-Response Relationship, Dr

2008

Other Studies

1 other study available for ketamine and Temporomandibular Disorders

ArticleYear
Antinociceptive effect of the cannabinoid agonist, WIN 55,212-2, in the orofacial and temporomandibular formalin tests.
    European journal of pain (London, England), 2010, Volume: 14, Issue:1

    Topics: Analgesics; Analgesics, Opioid; Anesthetics, Dissociative; Animals; Anti-Inflammatory Agents, Non-St

2010